Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 11 to 20 of 384

TitlePrioritisation programmeDecisionDecision date
Xeomin (botulinum neurotoxin type A) for treating lower or upper limb spasticity in people 2 to 17 years [TSID12297]None selectedNot selected
Gilteritinib + daunorubicin + cytarabine for Acute myeloid leukaemia (AML) [TSID12331]None selectedAwaiting decision
Epcoritamab + R-CHOP for Diffuse large B-cell lymphoma (DLBCL) [TSID12334]None selectedAwaiting decision
Transverse Tibial TransportInterventional proceduresAwaiting decision
Pozelimab with cemdisiran for treating symptomatic generalised myasthenia gravis [TSID12287]None selectedAwaiting decision
Ivacaftor–tezacaftor–elaxcaftor and ivacaftor for treating cystic fibrosis with at least 1 F508del mutation in the CFTR gene in people 1 to under 2 years [TSID12295]None selectedNot selected
Vanzacaftor–tezacaftor–deutivacaftor for treating cystic fibrosis with 1 or more responsive mutations in the CFTR gene in people 2 to 5 years [TSID12296]None selectedNot selected
Lanadelumab for preventing recurrent attacks of hereditary angioedema in people 2 years and over [TSID12298]None selectedNot selected
Thermal Probe Ablation for abdominal wall endometriosisNone selectedAwaiting decision
Sentinel Node Biopsy approved for pathological staging of clinically T1-T2 N0 oral cancerNone selectedNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All